Clinical Trial

Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

Study acronym: SENSE registry
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.
Trial Details
NCT Number NCT07549607
Lead Sponsor University of Leipzig
Conditions Primary Bilary Cirrhosis (PBC)
Enrollment 100 participants
Start Date 2026-04-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24